Stella Pharma Corporation announced a private placement of 4th stock acquisition rights on December 14, 2022. The transaction will include participation from SMBC Nikko Securities Inc.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
380 JPY | -1.30% | -1.81% | +33.33% |
02-13 | Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 | CI |
2023 | Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+33.33% | 75.28M | |
+55.55% | 823B | |
+42.31% | 641B | |
-6.83% | 352B | |
+17.15% | 324B | |
+7.09% | 301B | |
+14.02% | 241B | |
+1.64% | 223B | |
+13.66% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- 4888 Stock
- News Stella Pharma Corporation
- Stella Pharma Corporation announced that it expects to receive funding from SMBC Nikko Securities Inc.